Evidence map›Paper›PMID 32284911›Full record

ArticleGlobal advances in health and medicine2020

Study, Design, and Rationale of Noncommunicable Diseases in Nepal (NCD Nepal) Study: A Community-Based Prospective Epidemiological and Implementation Study in Rural Nepal.

Gagan Neupane, Sameer Acharya, Manoj Bhattarai, Ashish Upadhyay, Bishal Belbase, Manoj Bhandari, Drona Pandeya, Shatakshi Pokharel, Sulochana Ghimire, Gorakh Thapa and 6 more

Open access · goldAbstract read
In one paragraph

Article in Global advances in health and medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Gagan NeupaneHealth Foundation Nepal, Lalitpur, Nepal.ORCID https://orcid.org/0000-0002-8194-7794
Sameer AcharyaHealth Foundation Nepal, Lalitpur, Nepal.
Manoj BhattaraiHealth Foundation Nepal, Lalitpur, Nepal.
Ashish UpadhyayHealth Foundation Nepal, Lalitpur, Nepal.
Bishal BelbaseKarma Health, Dang, Nepal.
Manoj BhandariHealth Foundation Nepal, Lalitpur, Nepal.
Drona PandeyaHealth Foundation Nepal, Lalitpur, Nepal.
Shatakshi PokharelDepartment of Medicine, Star Hospital, Lalitpur, Nepal.
Sulochana GhimireHealth Foundation Nepal, Lalitpur, Nepal.
Gorakh ThapaHealth Foundation Nepal, Lalitpur, Nepal.
Biraj KarmacharyaDepartment of Community Programs, Dhulikhel Hospital Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal.
Madan Raj BhattHealth Foundation Nepal, Lalitpur, Nepal.
John A SpertusSaint Luke's Mid America Heart Institute, University of Missouri, Kansas City, Missouri.
Dinesh NeupaneNepal Development Society, Chitwan, Nepal.
Lava TimsinaHealth Foundation Nepal, Lalitpur, Nepal.
Yashashwi PokharelHealth Foundation Nepal, Lalitpur, Nepal.
Saint Luke's Hospital · USBoston University · USIndiana University – Purdue University Indianapolis · USJohns Hopkins University · USSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNoncommunicable diseases (NCDs) are the leading causes of deaths globally. Currently, there are limited high-quality data on the epidemiology and usefulness of community-based screening and treatment of NCDs in low-to-middle-income countries (LMIC), like Nepal. We describe the protocol of a community-based, longitudinal epidemiological study of screening and management of NCDs in rural Nepal.

methodsWe organize monthly mobile health clinics to screen NCDs among 40- to 75-year-old residents from municipal subdivision wards 3, 4, 6, and 7 of Ghorahi submetropolitan city, Dang, Nepal (approximately 406 km west of the capital, Kathmandu). We estimate a total of 7052 eligible participants. After obtaining informed consent, trained personnel will collect sociodemographic and lifestyle data, medical, medication, and family history using validated questionnaires, plus anthropometric measures and capillary glucose levels. We will screen for hypertension, diabetes, obesity, dyslipidemia, tobacco and alcohol use, self-reported physical activity, dietary habits, cardiovascular disease, stroke, chronic lung disease, cancer, and chronic kidney disease. We will also check hemoglobin A1C, lipid panel, serum creatinine, sodium, potassium, urine dipstick, and urine albumin-to-creatinine ratio in high-risk participants. We will offer lifestyle counseling, pharmacotherapy or refer to higher level care, where appropriate; routinely follow participants with NCDs for continuity of care; and follow individuals without NCDs but with elevated glucose, prehypertension or other risk factors every year, and those without risk factors every 2 years. We will monitor participants in the community to reduce attrition and to track all-cause and disease-specific mortality. DISCUSSION: Understanding the community burden of NCDs in resource-limited setting and testing effectiveness of community-based screening and management of NCDs will provide insights to develop national policy to address NCD burden in LMIC like Nepal.

Indexed as

cardiovascular diseasecommunity-based interventiondiabetesdisparityhypertensionlow- and middle-income countriesNepalnoncommunicable diseasesrural healthtobacco use

Identifiers

PMID32284911
PMCPMC7139172
OpenAlexW3015482650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.